Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab.
Conclusion: IOP rise is an important consideration as the chronicity of the condition can eventually lead to glaucomatous changes in eyes with already compromised vision. Follow-ups and use of appropriate therapy can be determined correspondingly.
PMID: 32051764 [PubMed]
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Diabetes | Endocrinology | Eyes | Fibre | Glaucoma | Lucentis | Opthalmology | Ranibizumab Injection | Statistics | Vitamin A